News

Latest Industry Updates

From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.

CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist
RBQM leader secures finalist position in the Data Analytics/Business Intelligence category at prestigious...
Read
Continuous Review Needs Consolidated Evidence and Fewer Dashboards
Continuous data review calls for fewer dashboards and one body of consolidated evidence, built with RBQM...
Read
CluePoints Shortlisted for 2026 Scrip Awards for the Third Time in Eight Years
Clinical Trial Vanguard covers CluePoints’ 2026 Scrip Awards shortlisting and what it signals about data...
Read
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss what...
Read
Why Time Savings Is the Largest Driver of RBQM's Financial Value
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain why...
Read
Why Quantifying the Financial Value of RBQM Has Been So Hard- and What This Study Did Differently
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how...
Read
1 2 3 … 36
CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist

RBQM leader secures finalist position in the Data Analytics/Business Intelligence category at prestigious awards. WAYNE, PA...

Continuous Review Needs Consolidated Evidence and Fewer Dashboards

Continuous data review calls for fewer dashboards and one body of consolidated evidence, built with RBQM...

Source: Contract Pharma

CluePoints Shortlisted for 2026 Scrip Awards for the Third Time in Eight Years

Clinical Trial Vanguard covers CluePoints’ 2026 Scrip Awards shortlisting and what it signals about data oversight...

Source: The Clinical Trial Vanguard

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss...

Source: Tufts Center for the Study of Drug Development

Why Time Savings Is the Largest Driver of RBQM’s Financial Value

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...

Source: Applied Clinical Trials

Why Quantifying the Financial Value of RBQM Has Been So Hard- and What This Study Did Differently

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...

Source: Applied Clinical Trials

CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins

The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....

Trial Complexity is the New Normal

Clinical trial complexity is now the norm: more endpoints, more procedures, narrower eligibility criteria, and more...

Source: pharmaphorum

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...

Making the Financial Case for Risk-Based Quality Management in Clinical Research- Q&A

New peer-reviewed research puts hard numbers to the financial value of RBQM, showing ROI multiples up...

Source: The Association of Clinical Research Professionals

The CRA of the Future

Clinical research associates are evolving from compliance-focused manual monitors to data-enabled strategic site partners, but organizations...

Source: Applied Clinical Trials

Applying Risk-Based Oversight to Ensure Real-World Data Integrity

Clinical trials have undergone a period of immense change. Use of real-world data (RWD) is increasing....

Source: PharmaLive

Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare

According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the...

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities

King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution...

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution...

UK Regulator Cites CluePoints’ Solutions in Updated Guidance

King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution...

CluePoints Senior Vice President, Europe, and APAC, to Speak at SCOPE 2022

John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful...

HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China

King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has...

CluePoints Wins Scrip Award for Clinical Advance of the Year 2021

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical...

CluePoints Chief Scientific Officer to Speak at CNS Summit Next Month

Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS...

CluePoints SVP of Business Development to Speak at Clinical Trials Europe

John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated...

CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution

King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...

CluePoints Chief Scientific Officer And Pfizer’s Global RBM Program Lead To Speak At #CQOF2021

Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum...

Will ICH E6 (R3) Unleash The Potential Of Risk-Based Trials?

Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day...

The Risk-Based Data Management (RBDM) Revolution

The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a...

Source: Clinical Research News

Leveraging Machine Learning and Deep Learning for Natural Language Processing in Clinical Data Management

Nicolas Huet, CluePoints Machine Learning Manager, discusses developments in the use of machine learning and deep...

Source: Pharmaceutical Outsourcing

The Future of RBQM Adoption

In the fifth and final part of this video interview series, Ken Getz, executive director and...

Source: Applied Clinical Trials

Potential Pitfalls Without RBQM Adoption

In part 4 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Increasing Comfortability With Adopting Risk-Based Approaches

In part 3 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Ken Getz of Tufts CSDD and Steve Young of CluePoints Discuss Stand Out Results from Recent RBQM Study

In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Ken Getz of Tufts CSDD Discusses RBQM Study Conducted with CluePoints and PwC

In part 1 of this video interview series with Ken Getz, executive director and research professor,...

Source: Applied Clinical Trials

Clinical Research 2.0 Must Embrace Change

We are at a tipping point in the adoption of Clinical Research 2.0. The evolution of...

Source: PM360

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...

Source: Applied Clinical Trials

Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trials

Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...

Source: Springer Link

Trendspotting: What’s Coming for Clinical Trials and Research in 2024

We spoke with leaders and experts in the Clinical Research community about their predictions for 2024.

...

Source: Clinical Research News

Ukraine War’s Impact on Clinical Research: Evidence from Key Risk Indicators

Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable...

Source: Applied Clinical Trials